The role of high-dose intravenous methylprednisolone in the treatment of varicella associated thrombocytopenic purpura

Turk J Pediatr. 1993 Jan-Mar;35(1):69-73.

Abstract

Two children with varicella associated thrombocytopenia are presented. Case 1, evidencing no mucosal or parenchymal bleeding was administered prednisone 2 mg/kg/day therapy after having been put under observation for a period of one week without medical treatment. There was an increase in the platelet count during the period of therapy culminating in a return to normal on the eighth day. Case 2, who was in poor clinical condition at presentation, was treated with high-dose intravenous methylprednisolone (HIVMP) 30 mg/kg/day, resulting in the platelet count returning to a normal level (180,000/mm3) on the second day of therapy. HIVMP therapy is recommended in the treatment of life-threatening cases of thrombocytopenia because of its rapid action, limited side-effects, and its low cost.

Publication types

  • Case Reports

MeSH terms

  • Chickenpox / drug therapy*
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Methylprednisolone / administration & dosage*
  • Platelet Count / drug effects
  • Purpura, Thrombocytopenic / drug therapy*

Substances

  • Methylprednisolone